Entering text into the input field will update the search result below

Kindred Biosciences' (KIN) CEO Richard Chin on Q4 2017 Results - Earnings Call Transcript

SA Transcripts profile picture
SA Transcripts

Kindred Biosciences, Inc. (KIN) Q4 2017 Earnings Conference Call March 1, 2018 4:30 PM ET


Richard Chin - Chief Executive Officer and President

Denise Bevers - Chief Operating Officer

Wendy Wee - Chief Financial Officer


Kevin DeGeeter - Ladenburg

Ben Haynor - Aegis Capital

Andrew D'Silva - B. Riley FBR

Sean Lee - H.C. Wainwright

David Westenberg - CL King


Welcome to the Fourth Quarter and Full-Year 2017 Financial Results Conference Call and Webcast for Kindred Biosciences. [Operator Instructions]

Please note that the remarks today will include forward-looking statements and that actual results could differ materially from those projected or implied in our forward-looking statements. For a description of important factors that could cause actual results to differ, we refer you to the forward-looking statements in today's press release and the notes on forward-looking statements in the company's SEC filings.

It is now my pleasure to turn over to KindredBio's CEO and President, Richard Chin. Dr. Chin, please proceed.

Richard Chin

Thank you, operator. Good afternoon and welcome to our fourth quarter and full-year 2017 financial results call. Joining me today from the management team of KindredBio are Denise Bevers, our Chief Operating Officer; and Wendy Wee, our Chief Financial Officer.

We are very pleased with our progress in 2017. In the space of a single year, we announced positive pivotal results for Zimeta Oral, which is our third consecutive positive pivotal study filed for registration of Mirataz in Europe, commissioned a cGMP biologics plant in California, purchased 180,000 square foot manufacturing plant in Kansas, and announced positive pilot study results for multiple molecules.

Last year, we also became the leading veterinary biopharmaceutical start-up as measured by market capitalization, a significant milestone that is a testament to our business model, and our team. I’m particularly proud of the remarkable team we

Recommended For You


To report an error in this transcript, .Contact us to add your company to our coverage or use transcripts in your business. Learn more about Seeking Alpha transcripts here. Your feedback matters to us!
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.